Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer

BACKGROUND & OBJECTIVES: An association between over-expression of proto-oncogene Her-2/neu and resistance to tamoxifen in estrogen receptor (ER) positive, primary and metastatic breast cancer has been suggested. HR+/Her-2/neu+ patients have a poor response to endocrine therapy, making this grou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: James, Rani, Thriveni, K., Krishnamoorthy, Lakshmi, Deshmane, Vijayalaxmi, Bapsy, P.P., Ramaswamy, Girija
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3100149/
https://ncbi.nlm.nih.gov/pubmed/21321422
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados